Teva Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade)
Source: SeekingAlpha
2025-12-23 18:08:28 ET
The investment thesis I laid out in my first article about Teva Pharmaceutical ( TEVA ) has finally played out. At the time of that article, TEVA was fluctuating around $16.50-$17.00 and is now above $31.50. ...
Read the full article on Seeking Alpha
For further details see:
Teva Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade)
Teva Pharmaceutical Industries Ltd
NASDAQ: TEVJF
TEVJF Trading
43530.77% G/L:
$28.36 Last:
100 Volume:
$28.36 Open:
TEVJF Latest News
June 06, 2025 09:44:00 am
Teva 2024 Healthy Future Report: Health System Strengthening and Capacity Building
TEVJF Stock Data
$39,634,050,594
1,138,314,769
N/A
264
N/A
Pharmaceuticals
Healthcare
IL
Tel Aviv
